Clinical Trials Browser

Phase EARLY_PHASE1 × Carcinoma, Renal Cell × denileukin diftitox × Clear all

NCT00278369 2013-05-22

Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Kidney Neoplasms